바이오스펙테이터

[유한양행/소렌토 합작회사] ㈜ 이뮨온시아 

경력사원 채용

ImmuneOncia is an immuno-oncology-centric biopharmaceutical company. Established in 2016 as a joint venture company between Yuhan (51%) and Sorrento (49%), ImmuneOncia will leverage both companies’ expertise in drug development and  antibody engineering. Our mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide.  

ImmuneOncia’s portfolio includes diverse immune checkpoint antibodies; the lead antibody IMC-001 is in Phase 1 clinical trial. 

Yuhan Corporation is a South Korea-based healthcare company founded in 1926. The company has positioned itself as one of the top pharmaceutical companies in terms of market cap and sales revenue in Korea. The core business consists of primary & specialty care, dietary supplements, household & animal care, and contract manufacturing of active pharmaceutical ingredients. It has a number of subsidiaries and a global presence in the form of joint ventures with Janssen (Belgium), the Clorox Company (USA), and Kimberly-Clark Corporation (USA). Yuhan (000100:KS) is a publicly-listed company traded on the Korea Stock Exchange. (http://eng.yuhan.co.kr)

Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento’s lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors. (http://sorrentotherapeutics.com) 

◆ 모집분야 및 자격요건

◆ 근무조건 

    - 근무시간 : 주 5일 근무 (1일 8시간)

    - 연봉수준 : 협의 후 결정

◆ 복리후생

    - 4대보험, 퇴직연금, 중식제공, 건강검진, 명절선물, 통근버스 운행

◆ 서류접수

    - 접수방법 : 이메일 제출 (hclee@immuneoncia.com)

    - 제출서류 : 이력서, 자기소개서(자유양식)

    - 접수기한 : 2019년 3월 20일(수)

◆ 전형절차

    서류전형 - 실무진 면접 - 임원 면접 - 최종 합격

      ※ 서류합격자 발표일 : 2019년 3월 27일(수)

      ※ 서류합격자에 한해 추가제출 서류를 받습니다.

◆ 문의사항

    - E-mail : 인사담당자 hclee@immuneoncia.com